"Stemcell Technologies"

Supplier: Stemcell Technologies

cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent.

Supplier: Stemcell Technologies

For characterization of gene expression associated with hPSC naïve or primed states.

Supplier: Stemcell Technologies

Transforming growth factor (TGF) beta 3 is a member of the TGF-β superfamily and regulates diverse cellular phenotypes. TGF-beta 3 binds to serine-threonine kinase type I and II receptors and activates signal transduction through SMAD2/3 proteins, thus regulating a variety of functions, including cell proliferation, differentiation, wound healing, apoptosis, and metabolism (Massagué; McDowell et al.). TGF-beta 3 enhances glycosaminoglycan production by mesenchymal stromal cells, stimulates scar-free healing, and improves glucose tolerance and phenotypic changes in adipocyte morphology (Hall et al.; Holton et al.). TGF-beta 3 induces proliferation of posterofrontal suture-derived mesenchymal stromal cells, and stimulates expression of fibroblast growth factors 2 and 18 (James et al.).

Supplier: Stemcell Technologies

Stimulating T cells with EBV (LMP2A) peptide pool releases downstream cytokines and upregulates activation markers, enabling antigen-specific T cells to be detected or isolated for analysis. EBV (LMP2A) peptide pool is a lyophilized mixture of 27 peptides from latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV; strain GD1), and consists of 15-mer peptides with 11-amino-acid overlaps that cover amino acids 1 to 118 on LMP2A. LMP2A contributes to the survival of EBV-transformed B cells (Mancao and Hammerschmidt) and mediates partial escape of infected B cells from recognition by EBV-specific CD8+ T cells (Rancan et al). Viral peptide pools are useful for a broad range of applications, including vaccine development, immunological research, and diagnostic assay development.

Supplier: Stemcell Technologies

For culture and expansion of human hematopoietic cells.